Home/ Supplements/ Calcium/ Calcium Citrate 630 mg plus Vitamin D-3

Calcium Citrate 630 mg plus Vitamin D-3

product on market Tablet or Pill Rite Aid Pharmacy Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Calcium and vitamin D3 are supported by strong evidence for maintaining bone density and supporting skeletal health. Vitamin D3 facilitates the intestinal absorption of calcium to optimize mineral levels in the body. Clinical research indicates these nutrients are effective for preventing bone loss in at-risk populations.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Calcium Citrate 630 mg plus Vitamin D-3
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
60
Servings
Single Vitamin and Mineral
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

12.5 mcg (63% DV)
Within RDA (0.8× RDA) 608 studies (A:16, B:251)
Calcium
630 mg (48% DV)

Other Ingredients

Cellulose Croscarmellose Sodium Silicon Dioxide Stearic Acid Magnesium Stearate Carnauba wax Vegetable Acetoglycerides Polyethylene Glycol Polysorbate 80
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take two (2) tablets daily with a full glass of water, preferably after a meal.

Warnings & Precautions

Warning: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Discontinue use two weeks prior to surgery.

Important: Tamper evident seal under cap. Do not use if printed seal is broken or missing.

Keep out of reach of children.

Formulation Notes

Essential for building strong bones

Potencies verified by NMI procedures #4000 and #5004. Conforms to USP <2091> for weight. Meets USP <2040> disintegration.

No preservatives added, no artificial colors, no artificial flavors.

Additional Information

Satisfaction guarantee If you're not satisfied, we'll happily refund your money.

Keep in a cool, dry place.

Metadata

Product Details

UPC / SKU0 11822 54060 5
DSLD Entry Date2022-07-21
Product TypeSingle Vitamin and Mineral
FormTablet or Pill
DSLD ID272814
Data Updated2026-04-11
Research

Research Evidence

511
Research Sources
57
Avg Quality
266
Meta Analysis
95
Systematic Review
76
Rct
49
Clinical Trial
12
Guideline
4
Regulatory Source
2
Cochrane Review
2
Other
2
Narrative Review
1
Openfda Safety
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A First-line drugs for hypertension
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Beta-blockers for hypertension
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Calcium →
Compare

Similar Products

View all Calcium products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.